Sarepta Gene Therapy Halt - Search News

Order byBest matchMost fresh

News

FDA, Sarepta and Gene therapy

· 2d · on MSN

Gene therapy maker Sarepta tells FDA it won’t halt shipments despite patient deaths

Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene therapy.

Continue reading

MedPage Today · 8h

Drugmaker Refuses FDA's Request to Pull Gene Therapy Tied to Patient Deaths

In surprise reversal, Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy

BioPharma Dive22m

Sarepta stops Elevidys shipments after standoff with FDA

Company CEO Doug Ingram said the pause was necessary for Sarepta to maintain a "productive and positive working relationship" ...

15hon MSN

Sarepta extends losses premarket after refusing FDA’s halt request

Sarepta Therapeutics (SRPT) shares fell as much as 4.8% in premarket trading Monday, poised to extend losses for a second ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results